The DOI matches its OpenAlex record; 26 of the 26 references it cites were found in a registry or an index.
Age, Sex, and Racial Differences in the Use of Standard Adjuvant Therapy for Colorectal Cancer
Abstract
PURPOSE: Dissemination of efficacious adjuvant therapies for resectable colorectal cancer has not been comprehensively described. Trends, patterns, and outcomes of adjuvant therapy for colorectal cancer, focusing on age, sex, and racial/ethnic differences, are reported. MATERIALS AND METHODS: Population-based random samples of patients diagnosed with colorectal cancer diagnosed in nine geographic areas were collected annually between 1987 and 1991 and in 1995 (n = 4,706). Data were obtained from medical record reviews. Multiple logistic regression was used to assess the use of standard adjuvant chemotherapy for colon and rectal cancers. The Cox proportional hazards model was used to assess 9-year mortality. RESULTS: From 1987 until 1995, the use of adjuvant therapy increased in all age groups. There was an increase starting in 1989 for colon and in 1988 for rectal cancer. Use of standard therapy was 78% for those younger than 55 years and 24% for those older than 80 years. White patients received standard therapy more frequently than African-Americans (odds ratio, 1.75; 95% confidence interval [CI], 1.09 to 2.83). All-cause and cancer-specific mortality exceeding 9 years were lower in those who received standard therapy (all-cause risk ratio [RR], 0.73; 95% CI, 0.61 to 0.88; cancer-specific RR, 0.87; 95% CI, 0.70 to 1.09). CONCLUSION: Standard adjuvant therapies for colorectal cancer disseminated into community practices during the 1990s. However, evidence exists of differential use of therapies by older patients and by African-Americans. The use of standard therapies in the general population is associated with lower mortality. Improved dissemination of standard adjuvant therapies to all segments of the population could help reduce mortality.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Charlson, M. E., Pompei, P., Ales, K. L., & MacKenzie, C. R. (1987) · Journal of Chronic Diseases · doi:10.1016/0021-9681(87)90171-8 · Cited by 49,742
Greenlee, R. T., Hill-Harmon, M. B., Murray, T., & Thun, M. (2001) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.51.1.15 · Cited by 3,288
Reducing Bias in Observational Studies Using Subclassification on the Propensity Score
Rosenbaum, P. R., & Rubin, D. B. (1984) · Journal of the American Statistical Association · doi:10.1080/01621459.1984.10478078 · Cited by 3,082
Levamisole and Fluorouracil for Adjuvant Therapy of Resected Colon Carcinoma
Moertel, C. G., Fleming, T. R., Macdonald, J. S., Haller, D. G., Laurie, J. A., Goodman, P. J., Ungerleider, J. S., Emerson, W. A., Tormey, D. C., Glick, J. H., et al. (1990) · New England Journal of Medicine · doi:10.1056/nejm199002083220602 · Cited by 2,256
The Effectiveness of Right Heart Catheterization in the Initial Care of Critically III Patients
Connors, A. F. (1996) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1996.03540110043030 · Cited by 2,210
Effective Surgical Adjuvant Therapy for High-Risk Rectal Carcinoma
Krook, J. E., Moertel, C. G., Gunderson, L. L., Wieand, H. S., Collins, R. T., Beart, R. W., Kubista, T. P., Poon, M. A., Meyers, W. C., Mailliard, J. A., et al. (1991) · New England Journal of Medicine · doi:10.1056/nejm199103143241101 · Cited by 1,879
Krieger, N. (1992) · American Journal of Public Health · doi:10.2105/ajph.82.5.703 · Cited by 1,654
O'Connell, M. J., Martenson, J. A., Wieand, H. S., Krook, J. E., Macdonald, J. S., Haller, D. G., Mayer, R. J., Gunderson, L. L., & Rich, T. A. (1994) · New England Journal of Medicine · doi:10.1056/nejm199408253310803 · Cited by 1,136
Adjuvant Therapy for Patients With Colon and Rectal Cancer
(1990) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1990.03450110090034 · Cited by 1,086
Predictive Margins with Survey Data
Graubard, B. I., & Korn, E. L. (1999) · Biometrics · doi:10.1111/j.0006-341x.1999.00652.x · Cited by 871
Ries, L. A. G., Wingo, P. A., Miller, D. S., Howe, H. L., Weir, H. K., Rosenberg, H. M., Vernon, S. W., Cronin, K., & Edwards, B. K. (2000) · Cancer · doi:10.1002/(sici)1097-0142(20000515)88:10<2398::aid-cncr26>3.0.co;2-i · Cited by 743
Mamounas, E., Wieand, S., Wolmark, N., Bear, H. D., Atkins, J. N., Song, K., Jones, J., & Rockette, H. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.5.1349 · Cited by 531
Wolmark, N. (2000) · Journal of the National Cancer Institute · doi:10.1093/jnci/92.5.388 · Cited by 530
Wolmark, N., Rockette, H., Mamounas, E., Jones, J., Wieand, S., Wickerham, D. L., Bear, H. D., Atkins, J. N., Dimitrov, N. V., Glass, A. G., et al. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.11.3553 · Cited by 493
Geronimus, A. T., & Bound, J. (1998) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a009673 · Cited by 485
Age and Adjuvant Chemotherapy Use After Surgery for Stage III Colon Cancer
Schrag, D., Cramer, L. D., Bach, P. B., & Begg, C. B. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.11.850 · Cited by 481
Efficacy of Adjuvant Fluorouracil and Folinic Acid in B2 Colon Cancer
(1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.5.1356 · Cited by 444
O'Connell, M. J., Laurie, J. A., Kahn, M., Fitzgibbons, R. J., Erlichman, C., Shepherd, L., Moertel, C. G., Kocha, W. I., Pazdur, R., Wieand, H. S., et al. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.1.295 · Cited by 417
Effects of health insurance and race on colorectal cancer treatments and outcomes
(2000) · American Journal of Public Health · doi:10.2105/ajph.90.11.1746 · Cited by 258
(1992) · Journal of Clinical Oncology · doi:10.1200/jco.1992.10.4.549 · Cited by 205
Impact of Patient and Provider Characteristics on the Treatment and Outcomes of Colorectal Cancer
Hodgson, D. C., Fuchs, C. S., & Ayanian, J. Z. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.7.501 · Cited by 194
Association of epidural analgesia with cesarean delivery in nulliparas
LIEBERMAN, E., MLANG, J., COHEN, A., DAGOSTINOJR, R., DATTA, S., & DFRIGOLETTOJR, F. (1996) · Obstetrics & Gynecology · doi:10.1016/s0029-7844(96)00359-6 · Cited by 172
Dignam, J. J., Colangelo, L. H., Tian, W., Jones, J. M., Smith, R. E., Wickerham, D. L., & Wolmark, N. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.22.1933 · Cited by 131
Detecting survival effects of socioeconomic status: Problems in the use of aggregate measures
Greenwald, H. P., Polissar, N. L., Borgatta, E. F., & McCorkle, R. C. (1994) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(94)90194-5 · Cited by 87
Colon Cancer Treatment in Rural North and South Carolina
Hawley, S. T., Hatzell, T. A., Paskett, E. D., Ricketts, T. C., Cooper, M. R., & Aldrich, T. E. (1999) · Cancer Detection and Prevention · doi:10.1046/j.1525-1500.1999.99042.x · Cited by 36
Adjuvant Treatment of Colorectal Cancer in the Elderly.
Aschele, C., Guglielmi, A., Tixi, L., Bolli, E., Mori, A., Lionetto, R., Rosso, R., & Sobrero, A. F. (1995) · PubMed · Cited by 14
Cited by
Colorectal cancer statistics, 2014
Siegel, R., DeSantis, C., & Jemal, A. (2014) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21220 · Cited by 2,562
Edwards, B. K., Ward, E., Kohler, B. A., Eheman, C., Zauber, A. G., Anderson, R. N., Jemal, A., Schymura, M. J., Lansdorp‐Vogelaar, I., Seeff, L. C., et al. (2010) · Cancer · doi:10.1002/cncr.24760 · Cited by 2,002
Jemal, A., Clegg, L. X., Ward, E., Ries, L. A. G., Wu, X., Jamison, P. M., Wingo, P. A., Howe, H. L., Anderson, R. N., & Edwards, B. K. (2004) · Cancer · doi:10.1002/cncr.20288 · Cited by 1,140
Edwards, B. K., Brown, M. L., Wingo, P. A., Howe, H. L., Ward, E., Ries, L. A. G., Schrag, D., Jamison, P. M., Jemal, A., Wu, X. C., et al. (2005) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/dji289 · Cited by 952
Self-citationWeir, H. K. (2003) · CancerSpectrum Knowledge Environment · doi:10.1093/jnci/djg040 · Cited by 867
Metadata
- Authors
- Potosky, A. L., Harlan, L. C., Kaplan, R. S., Johnson, K. A., & Lynch, C. F.
- Venue
- Journal of Clinical Oncology
- Publisher
- Lippincott Williams & Wilkins
- Published
- 2002-03-01
- Volume
- 20
- Issue
- 5
- Pages
- 1192-1202
- ISSN
- 0732-183X (ISSN-L)
- OpenAlex
- W2121973270
- Cited by
- 281
- References
- 26
- FWCI
- 6.44
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.